# US 2026/0276638 A1 · Extraction process of pancrelipase and evaluation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0276638 A1
- Document ID: US20260276638A1
- Status: Published application
- Kind: A1
- Application number: 19/681,459
- Filed: 2026-05-19
- Published: 2026-09-17
- Earliest claimed: 2021-03-23
- Assignees: Kashiv Biosciences, LLC
- Applicants: Kashiv BioSciences, LLC.
- Inventors: Raja Reddy Kuppili; Chintan Mineshkumar Vaywala; Parva Yogeshchandra Purohit; Mukesh Mahajan; Sanjaykumar Vanrajbhat Talpara
- Web page: https://patentgrep.com/patent/US20260276638A1

## CPC

- C12Q 1/34: involving hydrolase
- G01N 33/573: for enzymes or isoenzymes
- G01N 2333/92: Triglyceride splitting, e.g. by means of lipase
- G01N 2333/994: Pancreatin
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provided herein a pharmaceutical process used for an extraction of proteins from pancreatic sample and estimation of the extracted proteins. Moreover, the invention provides a use of suitable is selected from citrate-phosphate buffer and bicarbonate buffer capable to extract proteins from pancreatic sample. The invention further provides an analytical method to perform estimation of extracted proteins. This process provides an improved extraction method to quantify protein present in the pancreatic sample.

## Claims

### Claim 1

A process for an extraction of a pancreatic protein from a pancreatic protein sample, the process comprising:
a. dissolving the pancreatic protein sample in the buffer;
b. collecting the extracted pancreatic protein,
wherein the buffer is selected from citrate-phosphate buffer and bicarbonate buffer;
wherein the pancreatic protein sample comprises a pharmaceutical composition comprising:
one or more enzymes selected from lipase, protease, and amylase; and
one or more enzymes selected from Triacylglycerol lipase, Co-lipase, CEL lipase, Phospholipase A2, Trypsin, Chymotrypsin, Elastase, Carboxypeptidase A1, Carboxypeptidase B, Kallikrien glandular, and Alpha amylase.

### Claim 2 (depends on 1)

The process according to claim 1, wherein the extraction of the pancreatic protein is improved in comparison to an extraction process performed without using a buffer selected from citrate-phosphate buffer and bicarbonate buffer.

### Claim 3 (depends on 1)

The process according to claim 1, wherein:
the citrate-phosphate buffer concentration is selected from about 10 mM to about 200 mM; or
the bicarbonate buffer concentration is selected from about 10 mM to about 200 mM.

### Claim 4 (depends on 3)

The process according to claim 3, wherein:
the citrate-phosphate buffer concentration is selected from about 100 mM; or
the bicarbonate buffer concentration is selected from about 100 mM.

### Claim 5 (depends on 1)

The process according to claim 1, wherein the citrate phosphate buffer has a pH from about 6.0 to about 6.5.

### Claim 6 (depends on 1)

The process according to claim 1, wherein the bicarbonate buffer has a pH from about 9.5 to about 10.

### Claim 7 (depends on 1)

The process according to claim 1, wherein dissolving the pancreatic protein sample in the buffer is performed by stirring or shaking.

### Claim 8 (depends on 7)

The process according to claim 7, wherein stirring is performed at 200 rpm to 300 rpm.

### Claim 9 (depends on 8)

The process according to claim 8, wherein stirring is performed for about 20 minutes to about 30 minutes.

### Claim 10 (depends on 1)

The process according to claim 1, wherein the extracted pancreatic protein is further subjected to estimation of protein performed by using BCA, SDS-PAGE, CE-SDS, SE-HPLC, or RP-HPLC.

### Claim 11 (depends on 1)

The process according to claim 1, wherein the extracted pancreatic protein is further subjected to quantification of protein performed by using SDS-PAGE, CE-SDS, SE-HPLC, or RP-HPLC.

### Claim 12 (depends on 1)

The process according to claim 1, wherein the process provides more than about 80% yield of pancreatic protein.

### Claim 13 (depends on 1)

The process according to claim 1, wherein the process provides more than about 90% yield of pancreatic protein.

### Claim 14 (depends on 1)

The process according to claim 1, wherein the process provides more than about 98% yield of pancreatic protein.

### Claim 15 (depends on 1)

The process according to claim 1, wherein the extracted pancreatic protein comprises a protein selected from amylase, lipase and protease.

### Claim 16 (depends on 1)

The process according to claim 1, wherein the process provides a pharmaceutically acceptable pancreatic protein mixture comprising one or more enzymes selected from amylase, lipase and protease.

### Claim 17 (depends on 10)

The process according to claim 10, wherein the extracted pancreatic protein is further subjected to estimation of protein based on molecular weight by using CE-SDS.

### Claim 18 (depends on 10)

The process according to claim 10, wherein the extracted pancreatic protein is further subjected to estimation of purity profile by using RP-HPLC.

### Claim 19 (depends on 10)

The process according to claim 10, wherein the extracted pancreatic protein is further subjected to estimation of protein based on molecular weight by using SDS-PAGE.

### Claim 20 (depends on 10)

The process according to claim 10, wherein the extracted pancreatic protein is further subjected to estimation of purity profile by using SE-HPLC.
